The outbreak of COVID-19 had little impact on Rx/reimbursement adult incontinence, with pharmacies remaining open throughout the pandemic. Similar to retail adult incontinence, growth in Rx/reimbursement adult incontinence was driven by a natural increase in demand arising from an ageing population and the rising obesity rate.
Similar to retail and away-from-home sales of incontinence products, Essity and Attends remained the leading players with their respective Tena and Attends brands in 2020. These are typically the only incontinence brands offered by pharmacy chains.
Across the forecast period, there is not set to be a change in purchasing habits for Rx/reimbursement adult incontinence products due to COVID-19. Value growth will continue to be positive over the coming years, recording a CAGR of 8%.
Adult incontinence will continue to be a largely taboo subject in Norway, with sufferers commonly feeling a sense of shame or embarrassment in seeking help. Some adults, therefore, choose to forgo the medical assessment route and the reimbursement scheme for incontinence products.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Norway with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Norway, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page